When facing a diagnosis of cancer, there are many questions to be answered. Among them, am I a candidate for surgery, and if not what are my options? Do I need chemotherapy? What drugs or combinations are going to be best for me? How does my oncologist choose? For over 20 years, Rational Therapeutics has helped answer these important questions.
Using 3D functional profiling to analyze each patient’s living cancer cells, our Ex Vivo Analysis of Programmed Cell Death (EVA-PCD®) selects from amongst many comparable choices those drugs or combinations most likely to work for you. This “real-time” analysis with results available within 7 days can provide potentially life-saving information.
Today, most oncologists apply standard protocols based upon clinical trial results. These guidelines use a “One-Size-Fits-All” approach that may under estimate the uniqueness of your cancer’s biology. By selecting drug combinations in the laboratory, our analysis can help eliminate much of the guesswork. Our results have been shown to double response rates and can improve time-to-progression and survival. With these results, you and your oncologist will be equipped to make the most informed decision to treat YOUR cancer.
It is important to distinguish our analysis from genomic and molecular pathway analyses. These tests look for DNA or molecular abnormalities in your cancer and are performed on preserved samples (not living tissue). While these analyses can provide useful information, these tests cannot capture the unique features that determine how your tumor cells will respond in the body. Many factors influence whether a cancer cell lives or dies. Simply put, patients are more complex than the sum of their genes.
We are helping patients from around the world to significantly improve their chances as they confront this deadly disease. Call us today at (800) 542-HELP to see how we can help you or someone you love who is battling cancer.